References
The EPIC Investigators (1994) Use of monoclonal antibodies directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956–961
The EPILOG Investigators (1997) Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336:1689–1696
The CAPTURE Investigators (1997) Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 349:1429–1435
The EPISTENT Investigators (1998) Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352:87–92
Berkowitz SD, Sane DC, Sigmon KN et al (1998) Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization: evaluation of c7E3 for the prevention of ischemic complications (EPIC) study group. J Am Coll Card 32:311–319
Sitges M, Villa FP (1997) Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor. Int J Card 62:269–271
Kalra S, Bell M, Rihal CS (2001) Alveolar hemorrhage as a complication of treatment with abciximab. Chest 120:126–131
Haris U, Manzoor A, Shah, Tasbir ul-Islam et al. (2006) Abciximab and fatal pulmonary hemorrhage. Heart Lung 35:423–426
Aguirre FV, Topol EJ, Ferguson JJ, EPIC Investigators et al (1995) Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 91:2882–2890
Khanlou H, Tsiodras S, Eiger G et al (1998) Fatal alveolar hemorrhage and abciximab (ReoPro) therapy for acute myocardial infarction. Cathet Cardiovasc Diagn 44:313–331
Ali A, Patil S, Grady KJ, Schreiber TL (2000) Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors. Catheter Cardiovasc Interv 49:181–184
Albelda SM, Gefter WB, Epstein DM, Miller WT (1985) Diffuse pulmonary hemorrhage: a review and classification. Radiology 154(2):289–297
Cohen SA, Effron MB (1998) Abciximab and alveolar hemorrhage. NEJM 339:1861–1863
Said B, Ehab S, Bassam K, Istrael G et al (2006) Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. J Interven Cardiol 19:356–363
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vizzardi, E., D’Aloia, A., Zanini, G. et al. A case report of alveolar haemorrhage associated with severe thrombocytopenia induced by abciximab infusion in a patient with an acute coronary syndrome. Intern Emerg Med 3, 345–347 (2008). https://doi.org/10.1007/s11739-008-0167-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-008-0167-6